Patients with HIV had a 14% higher risk of sudden cardiac death than those without HIV, according to a large analysis of US veterans.
ESC Congress 2021: Results from the largest trial of its kind suggest that flu vaccination should be part of in-hospital treatment after myocardial infarction.
Aggressive control of systolic BP in adults aged 60 to 80 years significantly reduced CV risk, adding to evidence from the pivotal SPRINT trial in support of tight BP control.
Substituting regular salt with low-sodium alternative was found to reduce the risk of stroke, major cardiovascular events, and death in a new study presented at ESC Congress 2021.
In a pooled analysis of 2 key clinical trials, empagliflozin was beneficial in patients with heart failure with a reduced and preserved ejection fraction.
Consuming saturated fat from meat may be associated with a higher risk of CVD than other food sources, according to a new study presented at ESC Congress 2021.
Periodontitis was associated with an increased risk for CVD, particularly among patients with past myocardial infarction, in a new study being presented at ESC Congress 2021.
New findings being presented at ESC Congress 2021 highlight the need for smoking cessation services tailored to the specific needs of women.
With the post-LER PAD indication, rivaroxaban becomes the only anticoagulant in 2 decades to demonstrate safety and efficacy in the high-risk population.
Younger adults with myocardial infarction are more likely to be smokers, obese, and have hypertension than their peers, suggests a new study being presented at the ESC Congress 2021.